Lecanemab: First drug to slow Alzheimer’s too costly for NHS - BBC
- Lecanemab: First drug to slow Alzheimer’s too costly for NHS BBC
- UK health regulator rejects lecanemab as treatment for Alzheimer’s The Guardian
- Lecanemab licensed for adult patients in the early stages of Alzheimer’s disease GOV.UK
- First drug to slow Alzheimer’s progression will not be made available on the NHS The Independent
- Alzheimer’s wonder drug will not be available on the NHS The Telegraph